Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBMRead the press release from here
Dr. Yoshimura at the Institute of Science Tokyo has published "Efficacy and safety of diffusing alpha-emitter radiation therapy (DaRT) for head and neck cancer recurrence after radiotherapy."
東京科学大学の吉村亮一教授と研究チームによる論文「放射線療法後に再発した頭頸部がんに対する拡散型アルファ線治療（DaRT）の有効性と安全性」がInternational Journal of Clinical Oncologyに掲載
Comments